GEOVAX
GeoVax Labs operates as a biotechnology company focusing on developing vaccines that prevent and fight human immunodeficiency virus (HIV) infections that result in acquired immunodeficiency syndrome (AIDS). It was founded in 1988 and is based in Smyrna, Georgia, United States.
GEOVAX
Industry:
Biotechnology Health Care Medical Device
Founded:
1988-01-01
Address:
Smyrna, Georgia, United States
Country:
United States
Website Url:
http://www.geovax.com
Total Employee:
11+
Status:
Active
Contact:
6783847281
Total Funding:
28.05 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Google Universal Analytics Font Awesome Apache
Similar Organizations
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Vaxcyte
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Harriet L. Robinson Director HIV Vaccines @ GeoVax
Director HIV Vaccines
2016-01-01
Mark Newman Chief Scientific Officer @ GeoVax
Chief Scientific Officer
Mark W. Reynolds CFO @ GeoVax
CFO
2006-10-01
Don Hildebrand Chairman Emeritus @ GeoVax
Chairman Emeritus
2001-03-01
David A. Dodd Chairman, President and CEO @ GeoVax
Chairman, President and CEO
Founder
Stock Details
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - GeoVax
Official Site Inspections
http://www.geovax.com Semrush global rank: 1.34 M Semrush visits lastest month: 21.75 K
- Host name: sstwebdesign.sstwebdesign.com
- IP address: 170.249.217.130
- Location: West Chester United States
- Latitude: 39.9444
- Longitude: -75.5875
- Metro Code: 504
- Timezone: America/New_York
- Postal: 19382
More informations about "GeoVax"
About Us - GeoVax, Inc.
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers using novel proprietary platforms. …See details»
GeoVax - Wikipedia
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara (MVA) vector technology, with …See details»
Investors - GeoVax, Inc.
We also envision GeoVax as a preferred career-development organization to which highly innovative, competitive individuals aspire to develop careers. Our Values Although we may …See details»
GeoVax - Crunchbase Company Profile & Funding
GeoVax Labs operates as a biotechnology company focusing on developing vaccines that prevent and fight human immunodeficiency virus (HIV) infections that result in acquired …See details»
GeoVax Labs, Inc. - LinkedIn
1 day ago GeoVax Labs, Inc., (NASDAQ: GOVX) is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our Modified Vaccinia Ankara - Virus-Like Particle (MVA-VLP ...See details»
GeoVax Labs, Inc. (GOVX) Company Profile & Facts - Yahoo Finance
See the company profile for GeoVax Labs, Inc. (GOVX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
GeoVax - Org Chart, Teams, Culture & Jobs | The Org
View GeoVax's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
GeoVax Labs Announces $4.5 Million Registered Direct Offering …
4 days ago ATLANTA, GA - March 24, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines …See details»
GeoVax Labs, Inc. (GOVXW) Company Profile & Overview
Company profile for GeoVax Labs, Inc. (GOVXW) with a description, list of executives, contact details and other key facts.See details»
GeoVax - Funding, Financials, Valuation & Investors - Crunchbase
GeoVax Labs develops vaccines that prevent and fight HIV infections that result in AIDS.See details»
GeoVax Corp Overview
ATLANTA, GA, November 19, 2024 — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, …See details»
GeoVax Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 GeoVax has 5 employees at their 1 location and $81.53 k in annual revenue in FY 2022. See insights on GeoVax including office locations, competitors, revenue, financials, …See details»
Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: …
13 hours ago Geovax Labs Inc (GOVX) secures a $400 million award for COVID-19 vaccine development while navigating financial hurdles and global partnerships.See details»
GeoVax Achieves Significant Progress in Next-Generation COVID …
Jan 13, 2025 GeoVax estimates the annual market potential for GEO-CM04S1 to be approximately $30 billion, reflecting the critical medical need to better address high-risk …See details»
GeoVax - Overview, News & Similar companies | ZoomInfo.com
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer us ing novel proprietary platforms.See details»
GeoVax Labs, Inc. (GOVX) Company Profile & Facts - Yahoo Finance
See the company profile for GeoVax Labs, Inc. (GOVX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
GeoVax Reports 2024 Year-End Financial Results and Provides …
1 day ago GeoVax Reports 2024 Year-End Financial Results and Provides Business UpdateAids Vaccine Research - GeoVax, Inc.See details»
What's Next: Geovax Labs's Earnings Preview - Benzinga
2 days ago Geovax Labs GOVX will release its quarterly earnings report on Thursday, 2025-03-27. Here's a brief overview for investors ahead of the announcement. Analysts anticipate …See details»
GEOVAX LABS Earnings Results: $GOVX Reports Quarterly Earnings
21 hours ago GEOVAX LABS Hedge Fund Activity We have seen 11 institutional investors add shares of GEOVAX LABS stock to their portfolio, and 11 decrease their positions in their most …See details»
GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich ...
Feb 5, 2025 About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world's most threatening infectious diseases and …See details»